from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0731c/-

LFCtreatmentdescriptionclass of inhibitor

0.489

Amikacinug/mL Amikacintranslation

1.599

Cap5-10ug/mL Capreomycintranslation

1.658

Rox10-50 ug/mL Roxithromycintranslation

0.186

SM2-5 ug/mL Streptomycintranslation

2.486

Tet5-10 ug/mL Tetracyclinetranslation

0.701

Rif0.2-5ug/mL Rifampicintranscription

0.903

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.860

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.650

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.235

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.915

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.261

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.564

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.071

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.980

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.554

Econazole10-24 ug/mL Econazole (azole drug)respiration

-2.261

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.352

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.362

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.727

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.833

KCN5-20 ug/mL Potassium cyaniderespiration

-0.024

NaN30.2-2 mM Sodium aziderespiration

0.432

Nigericin50 uM Nigericinrespiration

-0.200

TRC10-150 ug/mL Triclosanrespiration

-0.042

TRZ10-25 ug/mL Thioridazinerespiration

-0.315

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.174

menadione6-10 ug/mL Menadionerespiration

-0.119

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.414

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.197

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.401

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.862

NRP_1Non-replicating persistence stage 1dosRassociated

-0.197

Amp0.2mg/mL AmpicillincellWall

0.437

Cephalexin20-100 ug/mL CephalexincellWall

0.404

Cerulenin0.32-5 ug/mL CerulenincellWall

0.636

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.157

EMB10-20 ug/mL EthambutolcellWall

-0.209

Eta12-40 ug/mL EthionamidecellWall

0.866

INH0.2-0.4 ug/mL IsoniazidcellWall

0.198

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.131

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.259

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.091

BZA0.12 mg/mL BenzamidearomaticAmides

0.445

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.356

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.579

H2O24 mM hydrogen peroxideDNAdamaging

0.427

Levo10 ug/mL LevofloxacinDNAdamaging

0.670

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.846

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.362

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.277

UVUV-irradiationDNAdamaging

-1.275

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.108

Antimycin12.5-50 ug/mL Antimycin A?

0.298

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.219

PA_110-50 ug/mL Antitubercular compound PA-1?

0.428

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.162

PA8240.2-2 ug/mL PA-824?

0.079

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.030

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.000

Verapamil50 uM Verapamil?

0.049

mercaptoethanol2 mM 2-Mercaptoethanol?

0.159

methoxatin10-20 ug/mL Methoxatin?